Loading…
Alkem Medtech, a subsidiary of Alkem Laboratories, has executed a binding offer to acquire up to a 55% stake in Swiss medical devices company Occlutech Holding AG for EUR 99.4 million (about ₹1,074 crore). The acquisition marks Alkem's entry into advanced cardiovascular devices.